日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Real-world use of polatuzumab vedotin combined with bendamustine and rituximab for patients with relapsed or refractory large B-cell lymphoma

在复发或难治性大B细胞淋巴瘤患者中,polatuzumab vedotin联合苯达莫司汀和利妥昔单抗的真实世界应用

Kim, Changgon; Yoon, Sang Eun; Kim, Hyun-Young; Cho, Duck; Cho, Junhun; Kim, Won Seog; Kim, Seok Jin

Production of Aloe vera Phytoplacenta Extract and Potential Applications in Skincare

芦荟胎盘提取物的生产及其在护肤领域的潜在应用

Jung, Seung Min; Kim, Hye-In; Kim, Soo-Yun; Jang, Sung Joo; Seo, Hyo Hyun; Lee, Jeong Hun; Kim, Ju-Duck; Cho, Won Kyong; Moh, Sang Hyun

Evaluating a combination treatment of NK cells and reovirus against bladder cancer cells using an in vitro assay to simulate intravesical therapy

使用体外试验模拟膀胱内治疗,评估 NK 细胞和呼肠孤病毒联合治疗膀胱癌细胞的效果

Yuree Lim, Jeehun Park, Joung Eun Lim, Minji Park, Seung Kwon Koh, Mijeong Lee, Sang-Ki Kim, Seung-Hwan Lee, Ki-Hoon Song, Dong Guk Park, Hyun-Young Kim, Byong Chang Jeong, Duck Cho

Synergistic therapeutic combination with a CAF inhibitor enhances CAR-NK-mediated cytotoxicity via reduction of CAF-released IL-6

与 CAF 抑制剂的协同治疗组合可通过减少 CAF 释放的 IL-6 增强 CAR-NK 介导的细胞毒性

Young Eun Lee #, Ga-Yeon Go #, Eun-Young Koh #, Han-Na Yoon, Minkoo Seo, Seung-Mo Hong, Ji Hye Jeong, Jin-Chul Kim, Duck Cho, Tae Sung Kim, Song Cheol Kim, Eunsung Jun, Mihue Jang

Intensified NK cell therapy in combination with low-dose chemoradiotherapy against human colorectal cancer

强化 NK 细胞治疗联合低剂量放化疗治疗人类结直肠癌

Huy Phuoc Quang Nguyen, Woo Kyun Bae #, Myong Suk Park, Ik-Joo Chung, Taek-Keun Nam, Jae-Uk Jeong, Tung Nguyen Thanh Uong, Duck Cho, Sang-Ki Kim, Meesun Yoon #1

Comparison of the different anti-CD16 antibody clones in the activation and expansion of peripheral blood NK cells

不同抗CD16抗体克隆对外周血NK细胞活化及扩增的影响比较

Jinho Kim, Minh-Trang Thi Phan, Ilwoong Hwang, Jeehun Park, Duck Cho

Expansion of cytotoxic natural killer cells in multiple myeloma patients using K562 cells expressing OX40 ligand and membrane-bound IL-18 and IL-21

使用表达 OX40 配体和膜结合 IL-18 和 IL-21 的 K562 细胞扩增多发性骨髓瘤患者的细胞毒性自然杀伤细胞

Jaya Lakshmi Thangaraj #, Minh-Trang Thi Phan #, SoonHo Kweon #, Jinho Kim, Jong-Min Lee, Ilwoong Hwang, Jeehun Park, Junsang Doh, Seung-Hwan Lee, Manh-Cuong Vo, Tan-Huy Chu, Ga-Young Song, Seo-Yeon Ahn, Sung-Hoon Jung, Hyeoung-Joon Kim, Duck Cho, Je-Jung Lee7

Selective Expansion of NKG2C+ Adaptive NK Cells Using K562 Cells Expressing HLA-E

使用表达 HLA-E 的 K562 细胞选择性扩增 NKG2C+ 适应性 NK 细胞

Minh-Trang Thi Phan, Jinho Kim, Seung Kwon Koh, Yuree Lim, Hongbi Yu, Mijeong Lee, Jong-Min Lee, Eun-Suk Kang, Hyun-Young Kim, Sang-Ki Kim, Ilwoong Hwang, Duck Cho

High-Throughput 3D In Vitro Tumor Vasculature Model for Real-Time Monitoring of Immune Cell Infiltration and Cytotoxicity

高通量 3D 体外肿瘤血管模型,用于实时监测免疫细胞浸润和细胞毒性

Jiyoung Song, Hyeri Choi, Seung Kwon Koh, Dohyun Park, James Yu, Habin Kang, Youngtaek Kim, Duck Cho, Noo Li Jeon

A Flow Cytometry-Based Whole Blood Natural Killer Cell Cytotoxicity Assay Using Overnight Cytokine Activation

基于流式细胞术的全血自然杀伤细胞细胞毒性测定,采用隔夜细胞因子激活

Jinho Kim, Minh-Trang Thi Phan, SoonHo Kweon, HongBi Yu, Jeehun Park, Kyeong-Hee Kim, Ilwoong Hwang, Sangbin Han, Min-Jung Kwon, Duck Cho